Biotech | November 08, 2021
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The students can interact with resident doctors and graduates of SGU
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
The NFI is published to promote the rational use of medicines in the country.
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
Acute therapies continue to report strong growth compared to chronic ones.
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Subscribe To Our Newsletter & Stay Updated
